Solara Active Pharma Sciences Ltd Disclosure Of Related Party Transactions |
12/05/2023| bse |
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
12/05/2023| bse |
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s |
12/05/2023| bse |
Solara Active Pharma Sciences Ltd Outcome Of Board Meeting For The Quarter And Year Ended March 31 2023 |
12/05/2023| bse |
Solara Active Pharma Sciences Ltd Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 |
06/05/2023| bse |
Solara Active Pharma Sciences Ltd Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue Of Convertible Warrants |
28/04/2023| bse |
Solara Active Pharma Sciences Ltd Certificate From A Practising Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 |
28/04/2023| bse |
Solara Active Pharma Sciences Ltd Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
13/04/2023| bse |
Solara Active Pharma Sciences Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
11/04/2023| bse |
Solara Active Pharma Sciences Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
10/04/2023| bse |
Load more